Balanced news tone
News Sentiment
GUBRA sentiment intelligence
Gubra A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-6.5% over one week, -0.6% over four weeks, trend inactive, and near fair-value range.
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Gubra A/S' shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 21:29
- Source
- TradingView
Gubra capital increase in connection with exercise of warrants
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 07:00
- Source
- TradingView
Gubra Q1 2026 slides: pipeline advances as CRO segment faces headwinds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 07:00
- Source
- Investing.com
Gubra FY 2025 slides: $2.2bn AbbVie deal drives record results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 27 Feb 2026 08:00
- Source
- Investing.com
Gubra recruits former Novo Nordisk director as new CTO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Feb 2026 08:00
- Source
- medwatch.com
Assessing Whether Gubra (CPSE:GUBRA) Looks Undervalued After Recent Share Price Gains
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jan 2026 08:00
- Source
- Market source
New Gubra CEO purchases shares worth DKK 1.6m
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Nov 2025 08:00
- Source
- medwatch.com
Gubra H1 2025 slides: AbbVie deal drives record revenue, GUBamy shows strong results
- Tone
- Positive 95/100
- Event
- Earnings
- Published
- 21 Aug 2025 07:00
- Source
- Investing.com
Gubra appoints a new chief executive
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Aug 2025 07:00
- Source
- medwatch.com
GUBRA A/S To Go Ex-Dividend On June 30th, 2025 With 9.22895 USD Special Dividend Per Share
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 26 Jun 2025 07:00
- Source
- Moomoo
AbbVie enters obesity space with $2.3bn Gubra deal
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 03 Mar 2025 08:00
- Source
- Pharmaceutical Technology
AbbVie and Gubra in billion-dollar deal for new obesity treatment
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 03 Mar 2025 08:00
- Source
- Biostock
GUBRA Forecast — Price Target — Prediction for 2027
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 04 Apr 2024 09:19
- Source
- TradingView
GUBRA Stock Price and Chart — OMXCOP:GUBRA
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Mar 2024 08:00
- Source
- TradingView
Gubra A/S: Shareholders Board Members Managers and Company Profile | DK0062266474
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Apr 2023 21:48
- Source
- marketscreener.com
Technical Analysis of Gubra A/S (OMXCOP:GUBRA)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Apr 2023 05:35
- Source
- TradingView